Inter Parfums offers 2010 forecast
This article was originally published in The Rose Sheet
Executive Summary
In 2010 Inter Parfums anticipates sales of $440 mil. - versus projected $400 mil. in fiscal 2009 sales - and earnings of $0.78 per diluted share, according to Nov. 23 release. "Our guidance is based primarily on the strength of our brands and on our new product launch schedule, and gives us the confidence that we will be able to achieve growth in both our European-based and U.S.-based operations," says Chairman and CEO Jean Madar. Firm plans to grow its Burberry brand with the launch of a cosmetics line in 30 to 40 shops worldwide, which will require a "significant" first-year investment, and expects to announce a new prestige fragrance license early in 2010. Inter Parfums plans more launches in 2010 than in 2009, including a fragrance line for Urban Outfitters' Anthropologie stores (1"The Rose Sheet" Nov. 16, 2009)
You may also be interested in...
Inter Parfums Preparing For Heavy Launch Activity In 2010
Inter Parfums has raised its full-year guidance, anticipating sales of $400 million based on "positive trends," and looks forward to a busy launch schedule in 2010
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.